Tickerlog
Monday 7th of February 2022 06:34:22 AM

Thermo Fisher launches Renvo Rapid PCR test to detect in-air coronavirus

Virus Graphs Eoneren/E+ via Getty Images
  • Thermo Fisher Scientific (NYSE:TMO) launched Renvo Rapid PCR Test that detects in-air SARS-CoV-2 pathogens.
  • The company said the Renvo Rapid PCR Test is performed on air samples collected using the Thermo Scientific AerosolSense Sampler.
  • The company added that the test is designed for environmental surveillance only, rather than diagnostic purposes.
  • The system uses Oscar PCR technology to shorten thermocycling times and produce on-site SARS-CoV-2 air sample results in 30 minutes, compared to four to 24-hour testing turnaround time previously available using the AerosolSense Sampler testing service.

TMO

Top gainers today
Top losers today